Cambridge, UK and Leiden, The Netherlands, 8th December 2014 / Sciad Newswire / Today ZoBio (Leiden, The Netherlands) and
ZoBio and Domainex Join Forces to Deliver Crucial Drug Target Information to support FORMA Therapeutics’ Drug Discovery Programs
Mon, 08/12/2014 - 07:00
Tue, 04/11/2014 - 14:30
SAN FRANCISCO, CA., 4th November 2014/Sciad Newswire/ — SynBioBeta, the leading community within the synthetic biology fie
Auspherix and Domainex Announce Collaboration to Develop New Drugs to Treat Antibiotic-resistant Bacterial Infections
Wed, 15/10/2014 - 06:00
Cambridge, UK and Sydney, Australia, 15 October 2014 / Sciad Newswire / Domainex Ltd.
Cambridge Research Biochemicals signs licensing deal with The Scripps Research Institute for ‘click’ chemistry
Wed, 01/10/2014 - 09:00
Cleveland, UK, 1st October 2014 / Sciad Newswire / Leading research peptide manufacturer Cambridge Re
Domainex Reports Success of its Lead Compound in Pre-clinical Model of COPD and Secures £1.4m Biomedical Catalyst Award
Wed, 09/07/2014 - 09:00
Cambridge, UK, 9th July 2014 / Sciad Newswire / Domainex Ltd, a UK-based drug discove
Tue, 03/06/2014 - 09:11
Cambridge Research Biochemicals and Key Organics announce an exclusive global supply & marketing agreement for peptides.
Tue, 20/05/2014 - 06:21
Cambridge Research Biochemicals renews Supply Contract with the Medical Research Council for a fourth year
Mon, 07/04/2014 - 09:27
Domainex programme shows great promise for the treatment of inflammatory diseases, such as Chronic Obstructive Pulmonary Disease (COPD)
Tue, 04/02/2014 - 16:38
University of Edinburgh and Selcia in £2.5 m bid to develop new drugs to target sleeping sickness the devastating tropical disease that threatens almost 70 million people in Africa.
Mon, 25/11/2013 - 09:56
Selcia celebrates the success of a recent inspection of its GMP Radiolabelling facility by the UK’s Medicines and Healthcare products Regulatory Agency (MHRA).